Gloria Sanclimens Pérez de Rozas

Gloria Sanclimens Pérez de Rozas has a diverse work experience spanning over several years. Gloria is currently working as the R&D BU Director at FAMAR since July 2020. Prior to that, they co-founded Gate2Brain and served as the Product Development & Founder.

From November 2018 to July 2020, they worked as the Product Development Director at Cantabria Labs Spain. Gloria also taught as a Faculty member at the Catalyst program in MIT School of Engineering from January 2019 to January 2020.

Earlier in their career, they held the position of Head of Project Management at Uriach from October 2016 to October 2018, and as the Head of R&D Finished Dosage Forms at Medichem, S.A. from January 2016 to October 2016.

As the R&D Director at Combino Pharm, S.L., they worked in various roles, including In-licensing and Project Manager from January 2012 to April 2013, and as a Project Manager from May 2008 to December 2011.

Gloria also had a role as an R&D Project Manager and Business Development Manager at Parc Científic de Barcelona from 2006 to 2008. Gloria started their career as a Postdoctoral Researcher at IQAC-CSIC in 2004.

Overall, Gloria Sanclimens Pérez de Rozas has a strong background in research and development, product development, project management, and business development.

Gloria Sanclimens Pérez de Rozas has a diverse education history. Gloria first attended Universitat de Barcelona from 1993 to 1998, where they obtained a Bachelor of Science degree in Chemistry. In 1999, they returned to Universitat de Barcelona to pursue a Master of Science degree in Organic Chemistry. Additionally, they attended Yale University School of Medicine in 2003 as a PhD student, focusing on Biomedical Engineering and Chemical Engineering. Moving forward, they completed their PhD in Organic Chemistry at Universitat de Barcelona from 2000 to 2005. Later, in 2009 and 2010, Gloria pursued a Master's Degree in Project Management at Business Engineering School La Salle Barcelona. Furthermore, they attended Esade from 2014 to 2016, participating in the Leadership Assessment and Development (LEAD) Program. Looking ahead, they have plans to attend Harvard University for the Harvard Management Mentor program in 2023.